The company is reportedly seen as an attractive acquisition target due to its diversified operations across two segments.

New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

Germany’s Merck KGaA is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical ...

Fennec Pharma’s partner Norgine Pharma launches Pedmarqsi in Germany: Monday, February 10, 2025, 14:00 Hrs [IST] Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, ...

Gerresheimer, a German manufacturer specialising in packaging for pharmaceuticals and cosmetics, is reportedly considering a potential sale. The company has engaged advisors to assess interest ...

Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and ...

The partnership will be a joint venture (JV) which the German pharma company will manage through its new Bayer LifeScience Centre (BLSC) unit, combining the 'molecular scissors' gene-editing ...

New Hampshire’s Bio X Cell, which has made a name for itself over the past quarter-century cranking out functional antibodies ...

As Donald Trump wields the threat of tariffs on EU and even UK goods, which industries would be worst affected and could the two trading partners develop closer ties? Data correspondent Alicja Hagopia ...

SpringWorks Therapeutics stock surged over Monday after a report from Reuters that German medical tech giant Merck KGaA could be close to acquiring the company.

Merck in Germany was possibly the earliest company ... With CAR-T (chimeric antigen receptor T-cell) drugs, pharma companies have taken the idea one step further and have been able to genetically ...